Bottom line
How much do AHSZX and BHCHX overlap?
35% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 30.4% of AHSZX's assets and 40.9% of BHCHX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings AHSZX and BHCHX have in common
| Holding | % of AHSZX | % of BHCHX | Overlap |
|---|---|---|---|
| Merck & Company Inc MRK | 4.18% | 2.48% | 2.48% |
| Welltower Inc WELL | 4.12% | 3.38% | 3.38% |
| Johnson & Johnson JNJ | 4.06% | 5.56% | 4.06% |
| Thermo Fisher Scientific Inc TMO | 4.00% | 3.91% | 3.91% |
| Unitedhealth Group Inc UNH | 3.61% | 3.28% | 3.28% |
| Teva Pharmaceutical Industries Ltd TEVA | 3.53% | 3.86% | 3.53% |
| Eli Lilly & Company LLY | 3.29% | 13.66% | 3.29% |
| Guardant Health Inc GH | 1.81% | 2.17% | 1.81% |
| Vertex Pharmaceuticals Inc VRTX | 1.80% | 2.61% | 1.80% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in AHSZX
- Dreyfus Treasury Obligations Cash Management — 6.51%
- Impulse Dynamics Ireland — 4.27%
- Bruker Corp — 3.98%
- Illumina Inc — 3.95%
- Cvs Health Corp — 3.67%
- Abbott Laboratories — 2.93%
- 10x Genomics Inc — 2.26%
- Novo Nordisk A/s — 2.24%
- Repligen Corp — 2.21%
- Royalty Pharma Plc — 1.94%
- Centene Corp — 1.91%
- Incyte Corp — 1.86%
- Pennant Group Inc (the) — 1.83%
- Arrowhead Pharmaceuticals Inc — 1.81%
- Corteva Inc — 1.65%
Only in BHCHX
- Mettler-Toledo International Inc — 5.60%
- Argenx SE — 4.23%
- Roivant Sciences Ltd — 3.88%
- RadNet Inc — 3.24%
- Billiontoone Inc — 2.84%
- Edwards Lifesciences Corp — 2.64%
- AstraZeneca PLC — 2.49%
- Madrigal Pharmaceuticals Inc — 2.12%
- Revolution Medicines Inc — 2.05%
- Elanco Animal Health Inc — 2.05%
- Kymera Therapeutics Inc — 2.01%
- Gilead Sciences Inc — 1.99%
- Natera Inc — 1.93%
- Intuitive Surgical Inc — 1.74%
- Protagonist Therapeutics Inc — 1.72%
Asset mix
| Asset type | AHSZX | BHCHX |
|---|---|---|
| Stocks | 91.9% | 97.7% |
| Cash & short-term funds | 6.5% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | AHSZX | BHCHX |
|---|---|---|
| US | 87.0% | 79.7% |
| NL | — | 4.5% |
| BM | 0.9% | 3.9% |
| IL | 3.5% | 3.9% |
| GB | 1.9% | 2.5% |
| DK | 2.2% | 0.4% |
| CA | — | 1.9% |
| FR | 1.6% | 1.0% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do AHSZX and BHCHX overlap?
What stocks do AHSZX and BHCHX have in common?
Should I own both AHSZX and BHCHX?
Which holds more stocks, AHSZX or BHCHX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.